Chemotherapy drugs, especially anthracyclines and HER2-targeted therapies, are known for their cardiotoxicity. They can cause direct damage to the heart cells, leading to weakened heart function and heart failure. Patients receiving these treatments require regular cardiovascular monitoring to detect early signs of heart damage.
